Rapport Therapeutics News

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Wendy B.

Nov 7 19:03 ET

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PEREZ ROBERT J

Nov 7 19:03 ET

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Silva Paul M

Nov 7 19:03 ET

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sanchez Ramiro

Nov 7 18:48 ET

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director PEREZ ROBERT J

Nov 7 18:48 ET

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Silva Paul M

Nov 7 18:38 ET

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Sanchez Ramiro

Nov 7 18:33 ET

Rapport Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Young Wendy B.

Nov 7 18:28 ET

Rapport Therapeutics | 10-Q: Quarterly report

Nov 7 07:33 ET

Rapport Therapeutics | 8-K: Current report

Nov 7 07:18 ET

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson(6.8%),Johnson & Johnson Innovation-JJDC, Inc.(6.8%)

Oct 18 17:25 ET

Rapport Therapeutics | 10-Q: Quarterly report

Aug 8 07:44 ET

Rapport Therapeutics | 8-K: Current report

Aug 8 07:24 ET

Rapport Therapeutics | SEC STAFF LETTER: Others

Jul 26 15:53 ET

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(13.624%),Abigail P. Johnson(13.624%)

Jul 10 10:15 ET

Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES

Jul 3 20:06 ET

Rapport Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(3.5 %),GOLDMAN SACHS & CO. LLC(3.5 %), etc.

Jun 24 21:06 ET

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(7.5 %),GOLDMAN SACHS & CO. LLC(7.5 %), etc.

Jun 21 16:56 ET

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%), etc.

Jun 20 16:03 ET

Rapport Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%), etc.

Jun 14 16:00 ET